Best Businesses In Town!
Monday, November 30, 2015
FDA Approves Second Antibody for Myeloma
(MedPage Today) -- Pivotal trial showed significant gain in PFS with elotuzumab
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment